CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,304 enrolled
Drug / intervention
Sodium Risedronatedrug
Likely dose
Sodium risedronate 75 mg tabletsAI-extracted
Key inclusion· 1
  • ✓Diagnosis of osteoporosis
Key exclusion· 0

None specified.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02089997
NCT02089997N/ACompleted
CompareCT.gov

Benet 75 mg Tablets Special Drug Use Surveillance: Long-term Use (12-month Treatment Survey)

Takeda·observational·Posted Mar 18, 2014·Updated Oct 19, 2018

In Brief

An observational study evaluating Sodium Risedronate for Osteoporosis. Completed, enrolled 3,304 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the safety and efficacy of sodium risedronate tablets (Benet 75 mg Tablets) in osteoporosis patients in daily medical practice, as well as to examine "the status of treatment compliance" - i.e., whether sodium risedronate tablets are taken properly in accordance with the prescribed once-monthly regimen

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoporosis
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 18, 2014
Enrollment StartMay 27, 2013
Primary CompletionApr 30, 2016
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.3 years ago

Interventions

Sodium Risedronatedrug

Sodium risedronate tablets